Quick Answer
CANNAPHARMARX, INC. reported Research And Development Expense of $324.1 thousand for the year ending 2014.
- This data is from CANNAPHARMARX, INC.'s annual report (Form 10-K), filed with the SEC on March 31, 2015.
- XBRL data for this metric is available from 2014 to 2014 (1 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: